What is Todd's paralysis (Transient focal neurological deficit)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Todd's paralysis is a self-limiting condition that requires no specific treatment, with management focusing on the underlying seizure disorder and monitoring until symptoms resolve. This condition is characterized by temporary weakness or paralysis in a limb or one side of the body, typically lasting from minutes to hours, and sometimes days [ 1 ]. The phenomenon occurs due to temporary exhaustion or inhibition of neurons in the brain's motor cortex following the excessive electrical activity of a seizure. According to a prospective cohort study by Hauser et al [ 1 ], Todd's paralysis can predict seizure recurrence, with a recurrence rate of 76%. However, the primary concern is the underlying seizure disorder, and treatment should be focused on managing seizures with appropriate anticonvulsant medications prescribed by a neurologist.

Some key points to consider in the management of Todd's paralysis include:

  • Resting in a safe position and monitoring until symptoms resolve
  • Distinguishing Todd's paralysis from stroke, as the symptoms can appear similar
  • Including information about Todd's paralysis in seizure action plans for patients with epilepsy
  • Focusing on treating the underlying seizure disorder with anticonvulsant medications, as the recurrence rate is higher in patients with abnormal EEG and acute symptomatic seizures [ 1 ]. A meta-analysis by Berg and Shinnar [ 1 ] found that increased risk is associated with abnormal neurologic examination and abnormal EEG, with a 36% seizure recurrence rate at 2 years in prospective studies.

It is essential to seek medical attention for new-onset Todd's paralysis to rule out other conditions and to manage the underlying seizure disorder effectively. A randomized, multicenter trial by the FIRST Group [ 1 ] found that untreated patients had a 2.8 times higher risk of relapse, highlighting the importance of appropriate treatment and management.

From the Research

Definition and Characteristics of Todd's Paralysis

  • Todd's paralysis is a neurological abnormality characterized by temporary limb weakness or hemiplegia, typically occurring following a seizure, without enduring consequences 2
  • The condition is often difficult to diagnose in individuals experiencing an acute ischemic stroke if they do not have a pre-existing history of epilepsy 2

Factors that Distinguish Todd's Paralysis

  • Todd's paralysis is commonly observed after partial seizures or generalized tonic-clonic seizures 2
  • The incidence of Todd's paralysis is greater if the epilepsy is associated with old age or stroke history 2
  • The duration of Todd's paralysis can range from minutes to days, depending on the type of seizure or whether the patient has experienced cortical structural damage 2
  • The etiology of Todd's paralysis is associated with cerebral perfusion abnormality after seizures 2

Treatment and Management

  • There is no direct evidence in the provided studies on the treatment and management of Todd's paralysis specifically 2, 3, 4, 5, 6
  • However, studies on levetiracetam and phenytoin suggest that these medications may be used in the treatment of seizures and status epilepticus, which can be related to Todd's paralysis 3, 4, 5, 6

Related Conditions and Medications

  • Status epilepticus is a neurologic emergency with potential for substantial mortality and morbidity, and levetiracetam may be used for SE that is refractory to benzodiazepine therapy 3
  • Levetiracetam is as effective as valproic acid or phenytoin for the cessation of SE in adults, with a superior side-effect profile 3, 5
  • Levetiracetam has a favourable safety profile in special populations, such as children, the elderly, and patients with hepatic dysfunction 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.